WASKYRA
STN: BLA 125846
Proper Name: etuvetidigene autotemcel
Tradename: WASKYRA
Manufacturer: Fondazione Telethon ETS
Indications:
- Ttreatment of pediatric patients aged 6 months and older and adults with Wiskott-Aldrich Syndrome (WAS) who have a mutation in the WAS gene for whom hematopoietic stem cell transplantation (HSCT) is appropriate and no suitable human leukocyte antigen (HLA)-matched related stem cell donor is available.
Product Information
Supporting Documents
- December 9, 2025 Approval Letter - WASKYRA
- December 9, 2025 Summary Basis for Regulatory Action - WASKYRA
- Letters, Reviews, Related Documents - WASKYRA